Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial.

Source:http://linkedlifedata.com/resource/pubmed/id/17725413

Download in:

View as

General Info

PMID
17725413